Aml Mohamed Nada

416 total citations
14 papers, 275 citations indexed

About

Aml Mohamed Nada is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Aml Mohamed Nada has authored 14 papers receiving a total of 275 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Endocrinology, Diabetes and Metabolism and 4 papers in Surgery. Recurrent topics in Aml Mohamed Nada's work include Gut microbiota and health (5 papers), Adipokines, Inflammation, and Metabolic Diseases (2 papers) and Diabetes and associated disorders (2 papers). Aml Mohamed Nada is often cited by papers focused on Gut microbiota and health (5 papers), Adipokines, Inflammation, and Metabolic Diseases (2 papers) and Diabetes and associated disorders (2 papers). Aml Mohamed Nada collaborates with scholars based in Egypt, United Arab Emirates and France. Aml Mohamed Nada's co-authors include Nihar Ranjan Dash, Mohammad Tahseen Al Bataineh, Ghalia Khoder, Ragab Hani Donkol, Pierre Bel Lassen, Eugeni Belda, Karine Clément, Maysaa El Sayed Zaki and Mostafa Abdelsalam and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Aml Mohamed Nada

12 papers receiving 270 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Aml Mohamed Nada 83 81 76 53 48 14 275
Martina De Siena 121 1.5× 127 1.6× 77 1.0× 139 2.6× 50 1.0× 33 443
F. Castellino 117 1.4× 127 1.6× 39 0.5× 70 1.3× 85 1.8× 12 357
Sara Samadi 65 0.8× 50 0.6× 66 0.9× 69 1.3× 13 0.3× 37 248
Jessica Dahmus 50 0.6× 110 1.4× 23 0.3× 107 2.0× 18 0.4× 14 333
José A González-Regueiro 76 0.9× 114 1.4× 38 0.5× 156 2.9× 17 0.4× 14 386
Simran Kaur 76 0.9× 79 1.0× 20 0.3× 43 0.8× 140 2.9× 25 349
Dominik Bergis 129 1.6× 28 0.3× 59 0.8× 68 1.3× 55 1.1× 18 352
Jinmei Yao 60 0.7× 107 1.3× 36 0.5× 136 2.6× 11 0.2× 10 262
Josephine Grace 105 1.3× 42 0.5× 75 1.0× 168 3.2× 39 0.8× 16 374
S. Dionisi 95 1.1× 236 2.9× 98 1.3× 58 1.1× 12 0.3× 17 521

Countries citing papers authored by Aml Mohamed Nada

Since Specialization
Citations

This map shows the geographic impact of Aml Mohamed Nada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aml Mohamed Nada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aml Mohamed Nada more than expected).

Fields of papers citing papers by Aml Mohamed Nada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aml Mohamed Nada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aml Mohamed Nada. The network helps show where Aml Mohamed Nada may publish in the future.

Co-authorship network of co-authors of Aml Mohamed Nada

This figure shows the co-authorship network connecting the top 25 collaborators of Aml Mohamed Nada. A scholar is included among the top collaborators of Aml Mohamed Nada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aml Mohamed Nada. Aml Mohamed Nada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Zaki, Maysaa El Sayed, et al.. (2025). Interleukin 6 Promoter Region Polymorphism in Patients With Type 2 Diabetes Mellitus, Study in One Egyptian Centre. International Journal of Immunogenetics. 52(5). 256–261.
2.
Zaki, Maysaa El Sayed, et al.. (2024). Study of Neutrophil Gelatinase Associated Lipocalin and Kidney Injury Molecule-1 in Patients with Type 2 Diabetes Mellitus Nephropathy. Clinical Laboratory. 70(03/2024). 1 indexed citations
3.
Zaki, Maysaa El Sayed, et al.. (2022). Study of single nucleotide polymorphism of vascular endothelium factor in patients with differentiated thyroid cancer. SHILAP Revista de lepidopterología. 8(1). 9–9.
4.
Bataineh, Mohammad Tahseen Al, Nihar Ranjan Dash, Pierre Bel Lassen, et al.. (2021). Publisher Correction: Revealing links between gut microbiome and its fungal community in Type 2 Diabetes Mellitus among Emirati subjects: A pilot study. Scientific Reports. 11(1). 6153–6153. 1 indexed citations
5.
Bataineh, Mohammad Tahseen Al, Nihar Ranjan Dash, Pierre Bel Lassen, et al.. (2021). Author Correction: Revealing links between gut microbiome and its fungal community in Type 2 Diabetes Mellitus among Emirati subjects: A pilot study. Scientific Reports. 11(1). 15102–15102. 7 indexed citations
6.
Nada, Aml Mohamed, et al.. (2021). Dapagliflozin improves cardiovascular risk factors in Emirati patients with T2DM. Therapeutic Advances in Endocrinology and Metabolism. 12. 2390915940–2390915940. 1 indexed citations
7.
Nada, Aml Mohamed, et al.. (2021). Clinical Predictors of Iron Deficiency Anemia in Emirati Population with T2DM. 11(2). 31–45. 1 indexed citations
8.
Dash, Nihar Ranjan, Ghalia Khoder, Aml Mohamed Nada, & Mohammad Tahseen Al Bataineh. (2021). Correction: Exploring the impact of Helicobacter pylori on gut microbiome composition. PLoS ONE. 16(8). e0256274–e0256274. 5 indexed citations
9.
Bataineh, Mohammad Tahseen Al, Nihar Ranjan Dash, Pierre Bel Lassen, et al.. (2020). Revealing links between gut microbiome and its fungal community in Type 2 Diabetes Mellitus among Emirati subjects: A pilot study. Scientific Reports. 10(1). 9624–9624. 38 indexed citations
10.
Dash, Nihar Ranjan, Ghalia Khoder, Aml Mohamed Nada, & Mohammad Tahseen Al Bataineh. (2019). Exploring the impact of Helicobacter pylori on gut microbiome composition. PLoS ONE. 14(6). e0218274–e0218274. 87 indexed citations
11.
Nada, Aml Mohamed, et al.. (2017). Cholecalciferol improves glycemic control in type 2 diabetic patients: a 6-month prospective interventional study. Therapeutics and Clinical Risk Management. Volume 13. 813–820. 10 indexed citations
12.
Nada, Aml Mohamed. (2015). Red cell distribution width in type 2 diabetic patients. Diabetes Metabolic Syndrome and Obesity. 8. 525–525. 62 indexed citations
13.
Donkol, Ragab Hani, et al.. (2013). Role of color Doppler in differentiation of Graves' disease and thyroiditis in thyrotoxicosis. World Journal of Radiology. 5(4). 178–178. 41 indexed citations
14.
Nada, Aml Mohamed. (2013). Effect of treatment of overt hypothyroidism on insulin resistance. World Journal of Diabetes. 4(4). 157–157. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026